FindTrial
Sign In

Cognitive-behavioral group therapy

BEHAVIORAL5 trials

Sponsors

Johns Hopkins Bloomberg School of Public Health, Yale University, Seoul National University Boramae Hospital, Dr Sébastien Grenier, CHU de Quebec-Universite Laval

Conditions

Alzheimer DiseaseAnxiety DisordersBRCA2 MutationBreast Cancer Susceptibility Gene (BRCA1) MutationDepressionFear of Cancer RecurrenceKidney Failure, ChronicQuality of Life

Unknown Phase

Preventing Anxiety Disorders in Urban Youth
CompletedNCT00073619
Johns Hopkins Bloomberg School of Public HealthAnxiety Disorders
Start: 2001-12-31End: 2011-07-31Updated: 2016-06-23
New Haven MOMS Partnership
CompletedNCT01665872
Yale UniversityDepression, Stress
Start: 2012-05-31End: 2017-06-30Updated: 2020-02-10
Cognitive-behavioral (CBT) in ESRD Patients With Depression
CompletedNCT02011139
Seoul National University Boramae HospitalDepression, Kidney Failure, Chronic, Quality of Life
Start: 2013-10-31End: 2014-12-31Updated: 2015-11-20
Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers
CompletedNCT03656159
Dr Sébastien GrenierAlzheimer Disease
Start: 2017-01-31End: 2019-06-30Updated: 2022-03-31
Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
RecruitingNCT06817694
CHU de Quebec-Universite LavalBRCA2 Mutation, Breast Cancer Susceptibility Gene (BRCA1) Mutation, Fear of Cancer Recurrence
Start: 2026-02-01End: 2028-12-01Target: 250Updated: 2026-03-31